The Academy of Managed Care Pharmacy (AMCP) thanks the Office of the National Coordinator for Health Information Technology (ONC) for the opportunity to provide comments in response to its proposed rule “21st Century Cures Act: Interoperability, Information Blocking, and the Health IT Certification Program” published in the Federal Register on March 4, 2019. AMCP appreciates ONC’s effort to remove barriers to interoperability and health information exchange.
Where We Stand: AMCP supports the use of therapeutic interchange programs as a part of a comprehensive approach to quality, cost‐effective patient care.
June 2019 News & Views: Educational Affairs Committee Plans Nexus 2019; Cathy Carroll Fund Now Receiving Donations; Cantrell Quoted in Washington Post; AMCP Releases Concepts for Effective PA Practices
The Academy of Managed Care Pharmacy (AMCP) thanks the Food and Drug Administration (FDA) for the opportunity to comment on its public hearing on Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products [FDA-2019-N-1132].
ICER's analysis of biologics used to treat asthma falls short of adequately addressing factors related to patients' health and quality of life, particularly those with severe, uncontrolled asthma, according to this JMCP article by the Asthma and Allergy Foundation of America's CEO.
Collaboration and transparency in the development of cost-effectiveness models can increase the credibility and relevance of these models for local decision making, according to this JMCP article.